Recombinant multi-species NSD1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis
Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NSD1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene encodes a protein containing a SET domain, 2 LXXLL motifs, 3 nuclear translocation signals (NLSs), 4 plant homeodomain (PHD) finger regions, and a proline-rich region. The encoded protein enhances androgen receptor (AR) transactivation, and this enhancement can be increased further in the presence of other androgen receptor associated coregulators. This protein may act as a nucleus-localized, basic transcriptional factor and also as a bifunctional transcriptional regulator. Mutations of this gene have been associated with Sotos syndrome and Weaver syndrome. One version of childhood acute myeloid leukemia is the result of a cryptic translocation with the breakpoints occurring within nuclear receptor-binding Su-var, enhancer of zeste, and trithorax domain protein 1 on chromosome 5 and nucleoporin, 98-kd on chromosome 11. Multiple transcript variants encoding distinct isoforms have been identified for this gene. [provided by RefSeq, Sep 2018]
The Alternative Names of target: ARA267,Androgen receptor coactivator 267 kDa protein,Androgen receptor-associated protein of 267 kDa,H3 lysine-36 specific,H3-K36-HMTase,Histone-lysine N-methyltransferase,KMT3B,Lysine N-methyltransferase 3B,NSD1,Nsd1,Nuclear receptor-binding SET domain-containing protein 1 (NR-binding SET domain-containing protein),SOTOS,SOTOS1,STO
Go
to NSD1 products collection
>>
(antibodies,
antigen, VLP, mRNA, ORF viral vector, etc)
Product information
| Catalog No. | Product Name | Species Reactivity |
|---|---|---|
| GM-Tg-hg-IP0132-Ag-1/ GM-Tg-hg-IP0132-Ag-2 | Human NSD1 protein | Human |
| GM-Tg-rg-IP0132-Ag-1/ GM-Tg-rg-IP0132-Ag-2 | Rat NSD1 protein | Rat |
| GM-Tg-mg-IP0132-Ag-1/ GM-Tg-mg-IP0132-Ag-2 | Mouse NSD1 protein | Mouse |
| GM-Tg-cynog-IP0132-Ag-1/ GM-Tg-cynog-IP0132-Ag-2 | Cynomolgus/Rhesus macaque NSD1 protein | Cynomolgus/ Rhesus macaque |
| GM-Tg-felg-IP0132-Ag-1/ GM-Tg-felg-IP0132-Ag-2 | Feline NSD1 protein | Feline |
| GM-Tg-cang-IP0132-Ag-1/ GM-Tg-cang-IP0132-Ag-2 | Canine NSD1 protein | Canine |
| GM-Tg-bovg-IP0132-Ag-1/ GM-Tg-bovg-IP0132-Ag-2 | Bovine NSD1 protein | Bovine |
| GM-Tg-equg-IP0132-Ag-1/ GM-Tg-equg-IP0132-Ag-2 | Equine NSD1 protein | Equine |
Size: 1mg | 10mg | 100mg
Product Description
| Catalog No. |
GM-Tg-hg-IP0132-Ag-1/ GM-Tg-hg-IP0132-Ag-2;
GM-Tg-rg-IP0132-Ag-1/ GM-Tg-rg-IP0132-Ag-2;
GM-Tg-mg-IP0132-Ag-1/ GM-Tg-mg-IP0132-Ag-2; GM-Tg-cynog-IP0132-Ag-1/ GM-Tg-cynog-IP0132-Ag-2; GM-Tg-felg-IP0132-Ag-1/ GM-Tg-felg-IP0132-Ag-2; GM-Tg-cang-IP0132-Ag-1/ GM-Tg-cang-IP0132-Ag-2; GM-Tg-bovg-IP0132-Ag-1/ GM-Tg-bovg-IP0132-Ag-2; GM-Tg-equg-IP0132-Ag-1/ GM-Tg-equg-IP0132-Ag-2 |
| Products Name | NSD1 protein |
| Species | Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine |
| Target Name | NSD1 |
| Protein Sub-location | Introcelluar Protein |
| Isotypes | Recombinant protein |
| Expression platform | Mammalian cell |
| Bioactivity validation | Affintiy&bioactivity validated by ELISA, cell culture validated. |
| Tag | His |
| Products description | Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine NSD1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic). |
| Purity | Purity: ≥95% (SDS-PAGE) |
| Application | In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
| Formulation & Reconstitution |
Lyophilized from GM's Protein Stability Buffer2
(PSB2,Confidential Ingredients) or PBS
(pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
| Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
About Gmab

GMab, developed by GeneMedi, constitutes an
advanced library of recombinant
monoclonal antibodies, each meticulously
designed to target specific molecular
entities. Leveraging the sophisticated
capabilities of GM’s Taurus™ and LIBRA™
platforms, GMab synthesizes antibodies
characterized by high binding affinity,
exceptional physicochemical stability, and
optimal developability profiles.
Through
expression in mammalian cell lines, GMab has
been established as a paradigmatic
reference antibody. It holds significance in
myriad domains of biological drug
discovery, encompassing cellular cultivation,
innovative assay methodologies,
strategic animal model systematization, in-depth
pharmacokinetic & pharmacodynamic
(PK/PD) modeling, and intricate mechanism of
action (MOA) investigations.